News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

YaFarm Technologies Updates on World Class Lab in ISCI Stem Cell Center



3/5/2013 9:20:13 AM

PITTSTON, ME--(Marketwire - March 05, 2013) - YaFarm Technologies, Inc. (PINKSHEETS: YFRM) (YaFarm, or the Company) announced today that the Integrative Stem Cell Institute (ISCI) has made significant progress on the construction of its World Class Lab in the ISCI Stem Cell Center in Cancun, Mexico. On February 8, 2013 YaFarm Technologies, Inc. announced that the Integrative Stem Cell Institute (ISCI), a premier provider of point-of-care, stem cell-based therapies, had initiated design and development of a new, world-class cell processing and culture laboratory in Cancun, Mexico. The ISCI is pleased to inform shareholders that progress on the class 10,000, ISO 7 clean room for the processing of autologous, mesenchymal cells for point-of-care therapies is ahead of schedule.

"The construction of the laboratory and clean room space is moving faster than anticipated," says David Audley, CEO of the ISCI. "Not only is the construction ahead of schedule, we believe we are setting a new industry standard." Mr. Audley continued, "The state-of-the-art facility has been specifically designed for sustainability. In addition, we have utilized green technologies and locally sourced materials to maximize environmental efficiency."

The laboratory space combines 'green' capability with the most advanced technology available to create an unparalleled scientific environment for clinical translation. "The resources available to the ISCI," continues Mr. Audley, "From barcode scanning to flow cytometry to advanced cellular imaging systems are leaps and bounds beyond what the typical regenerative medicine clinic has today." The ISCI is also unique in its use of cell preservation where a patient's own stem cell, once separated from the tissue, can be cyro-preserved (or banked) for later use.

The ISCI expects construction of the facility to end ahead of schedule and plans to open the new facility in mid April.

"The laboratory and clean room," continues Mr. Audley, "Are exceptional. They will be the benchmark against which every other facility will be judged."

About Integrative Stem Cell Institute (ISCI)
The Integrative Stem Cell Institute (ISCI) is a premier provider of point-of-care, stem cell-based therapies for patients from around the world. With a state of the art laboratory housed within the Hospital Galenia in Cancun, Mexico, the ISCI combines the most advanced scientific application of stem cells with second to none medical care within the structure of adaptive clinical trials to effectively track long term outcomes and assure patient safety. More information on the Integrative Stem Cell Institute is available at www.iscelli.com

SAFE HARBOR STATEMENT

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward looking statements are subject include, but are not limited to, the effect of government regulation, competition, adequate financing, and other material risks. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance, or achievements to be materially different from the statements made herein.


Contact:

The Integrative Stem Cell Institute
Contact:
Miranda Abrahams
Miranda@iscelli.com

Investor Contact
Atlanta Capital Partners, LLC
David Kugelman
(866) 692-6847
info@atlcp.com


Read at BioSpace.com


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES